| Joshua Armijo, | |
|
138 Harruby Dr, Calimesa, CA 92320-1704 | |
| (909) 723-7328 | |
| Not Available |
| Full Name | Joshua Armijo |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 138 Harruby Dr, Calimesa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326500240 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DEN.00203864 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Armijo, 138 Harruby Dr, Calimesa, CA 92320-1704 Ph: (909) 723-7328 | Joshua Armijo, 138 Harruby Dr, Calimesa, CA 92320-1704 Ph: (909) 723-7328 |
News Archive
Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.
The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported at the annual meeting of the American Society for Clinical Oncology in Chicago.
Two cell types work together to protect pancreatic tumors from destruction by the immune system. But, blocking this partnership may restore the system's ability to attack these same tumor cells.
Optum, an industry leader in health care payment integrity services, is working with SAS to further enhance its comprehensive health care anti-fraud, waste and abuse services. This enhanced solution combines detection, investigation, prevention, case development and recovery services to provide commercial health plans with a flexible approach to ensuring proper payments to care providers.
The Centers for Disease Control and Prevention (CDC) has prioritized finding effective treatment of Methicillin-resistant Staphylococcus aureus (MRSA), one of the most common bacterial pathogens and the single most deadly drug-resistant bacteria in the United States.
› Verified 9 days ago
Ike Arthur W Tomas, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1180 Calimesa Blvd, Calimesa, CA 92320 Phone: 909-570-4087 Fax: 909-570-4505 | |
Dr. Israel Armijo, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 138 Harruby Dr., Calimesa, CA 92320 Phone: 909-771-9403 | |
Richard L Parker, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1030 Calimesa Blvd, Calimesa, CA 92320 Phone: 909-795-6019 | |
Dr. Nathan Carlson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1007 Calimesa Blvd, Ste C, Calimesa, CA 92320 Phone: 909-795-5100 | |
Dr. James R Wise, DDSMS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1025 Calimesa Blvd, Ste. 2, Calimesa, CA 92320 Phone: 909-795-9707 Fax: 909-795-7599 | |
Dr. Sunee Limmeechokchai, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1115 Poinsettia Cir, Calimesa, CA 92320 Phone: 636-633-9559 |